HCV NS3/4A Protease Inhibitors
- Name
- HCV NS3/4A Protease Inhibitors
- Accession Number
- DBCAT004186
- Description
Not Available
- Drugs
Drug Drug Description Boceprevir A hepatitis C virus NS3/4A protease inhibitor used in combination with other medications to treat chronic hepatitis C genotype 1 infection. Boceprevir is not indicated as monotherapy. Simeprevir A direct-acting antiviral agent that inhibits HCV NS3/4A protease to treat chronic hepatitis C virus (HCV) infection in adults with HCV genotype 1 or 4. Telaprevir An NS3/4A viral protease inhibitor used in combination with other antivirals for the curative treatment of chronic Hepatitis C Virus infections. Paritaprevir A direct acting antiviral agent used in combination with other antiviral agents for the treatment of Hepatitis C Virus (HCV) infections. Grazoprevir An antiviral and NS3/4A protease inhibitor used to treat hepatitis C infections. Glecaprevir A Hepatitis C NS3/4A protease inhibitor used to treat Hepatitis C. Voxilaprevir A nonstructural protein 3 and 4a protease inhibitor used to treat Hepatitis C infections. - Drugs & Drug Targets